tradingkey.logo
๎™

Carlsmed Ord Shs

CARL
12.700USD
-0.240-1.85%
์ข…๊ฐ€ย 12/10, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
337.62M์‹œ๊ฐ€์ด์•ก
--P/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ ํšŒ์‚ฌ

Carlsmed Ord Shs ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ - -
ํšŒ์‚ฌ ์ด๋ฆ„- -
์ƒ์žฅ์ผ- -
CEO- -
์ง์› ์ˆ˜- -
์œ ํ˜•- -
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒ- -
์ฃผ์†Œ- -
๋„์‹œ- -
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†Œ- -
๊ตญ๊ฐ€- -
์šฐํŽธ ๋ฒˆํ˜ธ- -
์ „ํ™”- -
์›น์‚ฌ์ดํŠธ- -
์ข…๋ชฉ ์ฝ”๋“œ - -
์ƒ์žฅ์ผ- -
CEO- -

Carlsmed Ord Shs์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
--
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
--
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
--
Mr. Robert E. Mittendorff, M.D.
Mr. Robert E. Mittendorff, M.D.
Independent Director
Independent Director
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Kevin K. Sidow
Mr. Kevin K. Sidow
Independent Director
Independent Director
--
--
Mr. Leonard (Leo) Greenstein
Mr. Leonard (Leo) Greenstein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Philip (Phil) Young
Mr. Philip (Phil) Young
Independent Director
Independent Director
--
--
Ms. Jenifer Kamocsay
Ms. Jenifer Kamocsay
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
--
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
--
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
--
Mr. Robert E. Mittendorff, M.D.
Mr. Robert E. Mittendorff, M.D.
Independent Director
Independent Director
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--

์ˆ˜์ต ๋ถ„์„

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 23 hours ago
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 23 hours ago
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
๊ธฐํƒ€
34.01%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
๊ธฐํƒ€
34.01%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Corporation
31.29%
Venture Capital
21.22%
Individual Investor
11.54%
Investment Advisor/Hedge Fund
5.36%
Private Equity
4.71%
Investment Advisor
4.03%
Hedge Fund
2.55%
Pension Fund
0.67%
Research Firm
0.14%
๊ธฐํƒ€
18.49%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Dec 9
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Dec 9
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
68
10.32M
38.80%
+9.31M
2025Q3
68
10.32M
38.80%
+9.32M

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
B Capital Group Management LP
8.32M
31.29%
--
--
Sep 30, 2025
U.S. Venture Partners
5.64M
21.22%
+5.64M
--
Jul 24, 2025
OrbiMed Advisors, LLC
1.25M
4.71%
+400.74K
+47.04%
Sep 30, 2025
Cordonnier (Michael)
1.24M
4.66%
+1.24M
--
Jul 24, 2025
Janus Henderson Investors
1.09M
4.11%
+1.09M
--
Sep 30, 2025
Casey (Niall)
941.20K
3.54%
+941.20K
--
Jul 24, 2025
Root (Jonathan D)
484.00K
1.82%
+484.00K
--
Jul 24, 2025
BlackRock Institutional Trust Company, N.A.
355.10K
1.34%
+355.10K
--
Sep 30, 2025
Avidity Partners Management LP
321.91K
1.21%
+321.91K
--
Sep 30, 2025
The Vanguard Group, Inc.
227.19K
0.85%
+115.83K
+104.01%
Sep 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Dec 9
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Dec 9
์ด๋ฆ„
๋น„์œจ
iShares Micro-Cap ETF
0.02%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
iShares Micro-Cap ETF
๋น„์œจ0.02%
ProShares UltraPro Russell2000
๋น„์œจ0%
Proshares Ultra Russell 2000
๋น„์œจ0%
ProShares Hedge Replication ETF
๋น„์œจ0%
iShares Russell 2000 ETF
๋น„์œจ0%
iShares Russell 2000 Growth ETF
๋น„์œจ0%
iShares Russell 2000 Value ETF
๋น„์œจ0%
Global X Russell 2000 ETF
๋น„์œจ0%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Carlsmed Ord Shs์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Carlsmed Ord Shs์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
B Capital Group Management LP๋Š” 8.32M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 31.29%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
U.S. Venture Partners๋Š” 5.64M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 21.22%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
OrbiMed Advisors, LLC๋Š” 1.25M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 4.71%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Cordonnier (Michael)๋Š” 1.24M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 4.66%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Janus Henderson Investors๋Š” 1.09M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 4.11%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

Carlsmed Ord Shs์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Carlsmed Ord Shs์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
B Capital Group Management LP
U.S. Venture Partners
OrbiMed Advisors, LLC์ž…๋‹ˆ๋‹ค.

Carlsmed Ord Shs(CARL)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q4 ๊ธฐ์ค€์œผ๋กœ, Carlsmed Ord Shs์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 68๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 10.32M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 38.80%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q3 ๋Œ€๋น„ 0.00% ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

Carlsmed Ord Shs์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
-- ๊ธฐ์ค€, Carlsmed Ord Shs์˜ -- ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ --๋กœ ์ „์ฒด ๋งค์ถœ์˜ --%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™